CSBR - Champions Oncology Bozor kapitallashuvining balans qiymatiga nisbati

championsoncology.com (CSBR) korporativ emblemasi va logotipi

Champions Oncology (CSBR) biznesi onkologik dori vositalari tahliliga bo'lgan talabga tayanadi, bunda o'sma modellari to'plamining hajmi terapiyani aniq prognoz qilish uchun asosiy muvaffaqiyat omili bo'lib xizmat qiladi. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi va uning joriy ko'rsatkichi 17.16 darajasida turibdi. PDX testlariga bo'lgan barqaror farmatsevtika talabi va AI yechimlarining joriy etilishi real daromad keltirmoqda, pul oqimlari esa mijozlarning R&D budjetlariga bog'liqlik sababli nisbatan barqarorligicha qolmoqda.

Champions Oncology, Inc. (CSBR) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 30.10.2026gacha

Champions Oncology (CSBR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi championsoncology.com|CSBR - Adolatli qiymat konsensusi
- bozor kapitallashuvi statistikasi:
Bozor kapitallashuvi Champions Oncology Corp|CSBR - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Champions Oncology|CSBR - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati championsoncology.com|CSBR - Biznesning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Champions Oncology|CSBR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati championsoncology.com|CSBR - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Champions Oncology Corp|CSBR - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Champions Oncology|Tezkor likvidlik koeffitsiyenti championsoncology.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
CSBR - Sof daromad
Kompaniyaning har tomonlama tahlili:Champions Oncology
Champions Oncology yetakchi tovari

Ushbu koeffitsiyent kelajakdagi o'sish uchun premiumni aniqlash maqsadida aksiyalarning joriy bozor qiymatini kompaniyaning sof aktivlari bilan solishtiradi. Bu investorga aktivning haqiqiy kapitaliga nisbatan qanchalik hadda haddan tashqari sotib olinganligini baholash imkonini beradi. Narxning buki koeffitsiyenti tahlili bozor kutuvlari va moliyaviy hisobotlar o'rtasidagi farqni ochib beradi. Champions Oncology (CSBR) uchun ushbu farq uning shaxsiylashtirilgan test platformasining noyobligi bilan oqlanadi. Sog'liqni saqlash gigantlari bilan tuzilgan uzoq muddatli shartnomalardan kelib chiqadigan barqaror pul oqimlari yuqori bozor bahosini saqlab qolish uchun fundamental asos yaratadi.

Champions Oncology kimlar bilan raqobatlashadi

BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|halozyme.com - Balans qiymatiga nisbatan bozor qiymati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|HURA - Kapitallashuvning sof aktivlarga nisbati|TARA: Kapitallashuvning sof aktivlarga nisbati|FATE - Bozor kapitallashuvining balans qiymatiga nisbati|aadibio.com (WHWK) - Bozor qiymatining balans qiymatiga nisbati|TScan Therapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Bozor kapitallashuvining balans qiymatiga nisbati OSTX|Kapitallashuvning sof aktivlarga nisbati Radiopharm Theranostics Ltd RADX|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Balans qiymatiga nisbatan bozor qiymati ANL|Veru Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|TPST - Bozor kapitallashuvining balans qiymatiga nisbati|xiliotx.com (XLO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Renovaro|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC|Kairos Pharma Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OKUR|Balans qiymatiga nisbatan bozor kapitallashuvi w2.cytomed.sg|Bozor qiymatining balans qiymatiga nisbati Curis CRIS|Apollomics Inc. (APLM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|THAR - Bozor qiymatining balans qiymatiga nisbati|ADVB (Advanced Biomed Inc) - Kapitallashuvning balans qiymatiga nisbati|Genprex, Inc (GNPX) - Bozor qiymatining balans qiymatiga nisbati|CLDI - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati SBFM|XBIO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|PPBT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc. AONC|BGNE: Kapitallashuvning balans qiymatiga nisbati|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Elevation Oncology Inc. (ELEV) - Kapitallashuvning sof aktivlarga nisbati|icadmed.com (ICAD) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology (IKNA)|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Bozor qiymatining balans qiymatiga nisbati VIRX|Bozor qiymatining balans qiymatiga nisbati MorphoSys AG (MOR)|NAYA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)